Health And Wellness Industry News: Restoring Access Bill Introduced, Another Dietary Fiber Meets FDA Definition, More

Restoring Access to OTC bill introduced; West Virginia is 18th state to prohibit sales of DXM-containing cough suppressant to minors without a prescription; American Botanical Council presents Norman R. Farnsworth Excellence Award to Swiss pharmacist Otto Sticher; FDA adds another fiber to definition of dietary fiber; and Jarrow probiotics top ConsumerLab brand survey.

The Restoring Access to Medication Act introduced in the House would reinstate consumers’ direct purchases of OTC drugs with pre-tax- savings accounts and extends eligibility for using the accounts to feminine hygiene products. Flexible spending arrangements, health savings accounts and other pre-tax accounts since 2011, under a provision in the Affordable Care Act, have been eligible for OTC products only when consumers have prescriptions from doctors. The legislation was introduced by Reps. Ron Kind (D-WI), Grace Meng (D-NY), Jackie Walorski (R-IN) and Darin LaHood (R-IL). "For years, I have been fighting to add menstrual hygiene products to the list of HSA-FSA eligible items, and I'm proud to continue championing that effort in this new legislation. There is no reason to prohibit individuals from using their HSA-FSA funds to pay for menstrual products. They are basic and essential items and adding them to the list of eligible expenses would go a long way toward making these products more affordable and accessible to women," Meng said in a release.

The Consumer Healthcare Products Association has lobbied since Congress passed the ACA to again allow direct OTC purchases with pre-tax savings accounts. Bills proposing the change have been introduced in every session of Congress since then but none have gained sufficient support for passage. CHPA noted a study it released last week shows that 90% of US consumers prefer using OTC medicines before seeing health care providers and that, on average, each dollar spent on OTC medicines saves the US health care system $7.20, totaling nearly $146bn in annual savings. (Also see "Providing High Value, OTC Drugs Deserve Higher Profile In Health Care – CHPA" - HBW Insight, 19 March, 2019

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By 

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Time’s Up For Time-Line Mitopure Supplement Marketer’s Aging Claims In NAD Review

 

NAD says Amazentis didn’t substantiate cellular performance and muscle function claims for its supplements containing proprietary ingredient Mitropure but provided “a sufficiently reliable and reasonable basis” for “clinically proven to revitalize mitochondria.”

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

More from Wellness

Kennedy’s Balancing Act: Push MAHA, Trim Regs

 

Same-day announcements of RFIs from HHS secretary cover nutrient review process for infant formula and Kennedy’s “10-to-1 deregulatory policy” as part of president’s “broader federal effort to reduce regulatory burdens and increase transparency.”

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

Haleon Targets Low Income Households In Push To Reach 1bn More Consumers

 
• By 

Haleon wants to reach one billion more consumers by 2030 and plans to do this by tailoring products to those outside the highest income bracket. The UK-based firm's five-year growth plan will also see it generate £0.8bn in productivity savings.